Plaintiff Wins $28M Verdict in PA Xarelto Lawsuit Trial

Plaintiff Wins $28M Verdict in PA Xarelto Lawsuit Trial

Plaintiff Wins $28M Verdict in PA Xarelto Lawsuit Trial

A Pennsylvania jury awarded an Indiana woman a $28 million verdict in the state’s first Xarelto lawsuit trial. The plaintiff suffered gastrointestinal bleeding about a year after being prescribed the blood-thinning drug, according to a press release.

The verdict followed nearly a month of testimony in court of Common Pleas. The plaintiff’s attorneys accused Johnson & Johnson and Bayer of downplaying the potentially life-threatening side effects of the Xarelto drug.

It took the jury less than two days to come to a verdict, awarding the plaintiff and her husband $1.8 million in compensatory damages and $26 million in punitive damages.

Pharmaceutical giants Bayer and Johnson & Johnson have been named in more than 20,000 lawsuits related to the Xarelto drug. Approximately 2,000 of those lawsuits are part of the mass tort program in Philadelphia.


About TriMark

TriMark Legal Funding provides non-recourse pre-settlement and post-settlement Xarelto lawsuit loans to injured plaintiffs nationwide.

This post originally appeared here: https://www.legalscoops.com/plaintiff-wins-28m-verdict-in-pa-xarelto-lawsuit-trial/

Click here to see the full original article.

Still have questions?

Call (877) 932-2628 and speak with one of our legal funding experts.

* Word-Use Disclaimer

Legal funding is not a loan. It is the non-recourse purchase of an equitable lien in plaintiffs’ legal claims. Words such as ‘loans,’ ‘lending,’ ‘borrow,’ etc., are used for marketing purposes only.
More info

TriMark Legal Funding LLC
1056 Green Acres Rd #102
Eugene, OR 97408